394 related articles for article (PubMed ID: 19740444)
1. Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device).
Brod M; Hammer M; Christensen T; Lessard S; Bushnell DM
Health Qual Life Outcomes; 2009 Sep; 7():83. PubMed ID: 19740444
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight).
Brod M; Hammer M; Kragh N; Lessard S; Bushnell DM
Health Qual Life Outcomes; 2010 Feb; 8():19. PubMed ID: 20137088
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO).
Brod M; Højbjerre L; Bushnell DM; Hansen CT
Qual Life Res; 2015 Dec; 24(12):2971-84. PubMed ID: 26094008
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.
Brod M; Højbjerre L; Adalsteinsson JE; Rasmussen MH
J Clin Endocrinol Metab; 2014 Apr; 99(4):1204-12. PubMed ID: 24438372
[TBL] [Abstract][Full Text] [Related]
5. Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures.
Brod M; Christensen T; Hammer M; Busk AK; Bushnell DM
Qual Life Res; 2011 Nov; 20(9):1513-8. PubMed ID: 21424338
[TBL] [Abstract][Full Text] [Related]
6. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
Brod M; Blum SI; Bushnell DM; Ramasamy A
Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
[TBL] [Abstract][Full Text] [Related]
8. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
Polonsky WH; Fisher L; Hessler D; Edelman SV
Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
[TBL] [Abstract][Full Text] [Related]
9. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience.
Brod M; Skovlund SE; Wittrup-Jensen KU
Qual Life Res; 2006 Apr; 15(3):481-91. PubMed ID: 16547787
[TBL] [Abstract][Full Text] [Related]
10. Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment.
Regnault A; Viala-Danten M; Gilet H; Berdeaux G
BMC Ophthalmol; 2010 Feb; 10():1. PubMed ID: 20122146
[TBL] [Abstract][Full Text] [Related]
11. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
[TBL] [Abstract][Full Text] [Related]
13. The development of a new measure of quality of life for young people with diabetes mellitus: the ADDQoL-Teen.
McMillan CV; Honeyford RJ; Datta J; Madge NJ; Bradley C
Health Qual Life Outcomes; 2004 Nov; 2():61. PubMed ID: 15535888
[TBL] [Abstract][Full Text] [Related]
14. Validation of a Patient-reported Outcome (PRO) Measure and a Clinician-reported Outcome (CRO) Measure to Assess Satisfaction with Pharmacologic Stress Agents for Single-photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI).
Hudgens S; Spalding J; Chaudhari P
Clin Ther; 2016 May; 38(5):1141-50. PubMed ID: 26992664
[TBL] [Abstract][Full Text] [Related]
15. LC-PROM: Validation of a patient reported outcomes measure for liver cirrhosis patients.
Zhang Y; Yang Y; Lv J; Zhang Y
Health Qual Life Outcomes; 2016 May; 14():75. PubMed ID: 27165036
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of the AFImpact: An Atrial Fibrillation-Specific Measure of Patient-Reported Health-Related Quality of Life.
Coyne KS; Edvardsson N; Rydén A
Value Health; 2017 Dec; 20(10):1355-1361. PubMed ID: 29241895
[TBL] [Abstract][Full Text] [Related]
17. Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
Polonsky WH; Fisher L; Hessler D; Edelman SV
Diabetes Technol Ther; 2015 Nov; 17(11):773-9. PubMed ID: 26167948
[TBL] [Abstract][Full Text] [Related]
18. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
Kimman ML; Rotteveel AH; Wijsenbeek M; Mostard R; Tak NC; van Jaarsveld X; Storm M; Wijnsma KL; Gelens M; van de Kar NCAJ; Wetzels J; Dirksen CD
Patient; 2017 Oct; 10(5):629-642. PubMed ID: 28357591
[TBL] [Abstract][Full Text] [Related]
19. Patients' assessment of chronic illness care: a validation study among patients with type 2 diabetes in Finland.
Simonsen N; Koponen AM; Suominen S
BMC Health Serv Res; 2018 Jun; 18(1):412. PubMed ID: 29871638
[TBL] [Abstract][Full Text] [Related]
20. Development of diabetes-specific quality of life module to be in conjunction with the World Health Organization quality of life scale brief version (WHOQOL-BREF).
Lin CY; Lee TY; Sun ZJ; Yang YC; Wu JS; Ou HT
Health Qual Life Outcomes; 2017 Aug; 15(1):167. PubMed ID: 28835235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
